New Zealand markets close in 55 minutes

BioLife Solutions, Inc. (BLFS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
21.72+0.63 (+2.99%)
At close: 04:00PM EDT
21.72 0.00 (0.00%)
After hours: 04:02PM EDT

BioLife Solutions, Inc.

3303 Monte Villa Parkway
Suite 310
Bothell, WA 98021
United States
425 402 1400

IndustryMedical Instruments & Supplies
Full-time employees409

Key executives

NameTitlePayExercisedYear born
Mr. Roderick de GreefCEO & Chairman1.63MN/A1960
Mr. Troy WichtermanChief Financial Officer485.2k17.47k1985
Ms. Karen FosterChief Quality & Operations Officer395.2kN/A1960
Dr. Aby J. Mathew Ph.D.Chairman of Scientific Advisory Board, Executive VP & Chief Scientific Officer448.2k2.68M1972
Mr. Todd BerardChief Marketing Officer286.49kN/A1969
Ms. Sarah Aebersold J.D.Chief Human Resources OfficerN/AN/A1977
Mr. Garrie Richardson B.Sc., M.B.A.Chief Revenue OfficerN/AN/A1973
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Corporate governance

BioLife Solutions, Inc.’s ISS governance QualityScore as of 1 May 2024 is 6. The pillar scores are Audit: 10; Board: 8; Shareholder rights: 3; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.